Back

dr. F.Y.F.L. (Filip) de Vos

dr. F.Y.F.L. (Filip) de Vos

Assistant Professor - medical

Show full profile

Research Output (96)

Study protocol of the GLOW study:maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study

van Opijnen Mark P, Broekman Marike L D, de Vos Filip Y F, Cuppen Edwin, van der Hoeven Jacobus J M, van Linde Myra E, Compter Annette, Beerepoot Laurens V, van den Bent Martin J, Vos Maaike J, Fiebrich Helle-Brit, Koekkoek Johan A F, Hoeben Ann, Kho Kuan H, Driessen Chantal M L, Jeltema Hanne-Rinck, Robe Pierre A J T, Maas Sybren L N 4 Nov 2022, In: BMC Medical Genomics [E]. 15

Attitudes Toward Striving for Quality and Length of Life Among Patients With Advanced Cancer and a Poor Prognosis

van der Velden Naomi C A, van Laarhoven Hanneke W M, Nieuwkerk Pythia T, Kuijper Steven C, Sommeijer Dirkje W, Ottevanger Petronella B, Fiebrich Helle-Brit, Dohmen Serge E, Creemers Geert-Jan, de Vos Filip Y F L, Smets Ellen M A, Henselmans Inge 6 Oct 2022, In: JCO oncology practice. 18 , p. e1818-e1830

Characteristics of patients with advanced cancer preferring not to know prognosis:a multicenter survey study

van der Velden Naomi C A, van Laarhoven Hanneke W M, Burgers Sjaak A, Hendriks Lizza E L, de Vos Filip Y F L, Dingemans Anne-Marie C, Jansen Joost, van Haarst Jan-Maarten W, Dits Joyce, Smets Ellen Ma, Henselmans Inge 1 Sep 2022, In: BMC Cancer. 22 , p. 1-12

Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms:Results of a Randomized Controlled Trial

Schuit Anouk S, Holtmaat Karen, Coupé Veerle M H, Eerenstein Simone E J, Zijlstra Josée M, Eeltink Corien, Becker-Commissaris Annemarie, van Zuylen Lia, van Linde Myra E, Menke-van der Houven van Oordt C Willemien, Sommeijer Dirkje W, Verbeek Nol, Bosscha Koop, Nandoe Tewarie Rishi, Sedee Robert-Jan, de Bree Remco, de Graeff Alexander, de Vos Filip, Cuijpers Pim, Verdonck-de Leeuw Irma M, Jansen Femke Sep 2022, In: Current oncology (Toronto, Ont.). 29 , p. 6186-6202 17 p.

Prognostic factors among patients with brain metastases from cancer of unknown primary site

Simões Padilla C, Ho V K Y, van der Strate I H, Leenders W P J, de Vos F Y F L, Veldhuijzen van Zanten S E M, Loef C 17 Aug 2022, In: Journal of Neuro-Oncology. 159 , p. 647-655 9 p.

Complications, compliance, and undertreatment do not explain the relationship between cognition and survival in diffuse glioma patients

van Kessel Emma, Krijnen Eva A, IJpelaar Suzanne, Huenges Wajer Irene M C, Ruis Carla, Seute Tatjana, De Vos Filip Y F L, Verhoeff Joost J C, Robe Pierre A, van Zandvoort Martine J E, Snijders Tom J Aug 2022, In: Neuro-Oncology Practice. 9 , p. 284-298 15 p.

Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs:A randomized controlled trial

Schuit Anouk S, Holtmaat Karen, Lissenberg-Witte Birgit I, Eerenstein Simone E J, Zijlstra Josée M, Eeltink Corien, Becker-Commissaris Annemarie, van Zuylen Lia, van Linde Myra E, Menke-van der Houven van Oordt C Willemien, Sommeijer Dirkje W, Verbeek Nol, Bosscha Koop, Tewarie Rishi Nandoe, Sedee Robert-Jan, de Bree Remco, de Graeff Alexander, de Vos Filip, Cuijpers Pim, Verdonck-de Leeuw Irma M Jul 2022, In: The Lancet Regional Health - Europe. 18 , p. 1-11

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter

Lim Michael, Weller Michael, Idbaih Ahmed, Steinbach Joachim, Finocchiaro Gaetano, Raval Raju R, Ansstas George, Baehring Joachim, Taylor Jennie W, Honnorat Jerome, Petrecca Kevin, De Vos Filip, Wick Antje, Sumrall Ashley, Sahebjam Solmaz, Mellinghoff Ingo K, Kinoshita Masashi, Roberts Mustimbo, Slepetis Ruta, Warad Deepti, Leung David, Lee Michelle, Reardon David A, Omuro Antonio 2 May 2022, In: Neuro-Oncology. 24 , p. 1935-1949 15 p.

Conventional MRI Criteria to Differentiate Progressive Disease from Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas

Flies Christina M, van Leuken Karlijn H, Voorde Marlies Ten, Verhoeff Joost J C, De Vos Filip Y F, Seute Tatjana, Robe Pierre A, Witkamp Theodoor D, Hendrikse Jeroen, Dankbaar Jan Willem, Snijders Tom J 18 Apr 2022, In: Neurology. 99 , p. e77-e88

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations:A Multicenter Phase II Study

Lassman Andrew B, Sepúlveda-Sánchez Juan Manuel, Cloughesy Timothy, Gil-Gil Miguel J, Puduvalli Vinay K, Raizer Jeffrey, De Vos Filip Y F, Wen Patrick Y, Butowski Nicholas, Clement Paul M J, Groves Morris D, Belda-Iniesta Cristobal, Giglio Pierre, Soifer Harris S, Rowsey Steven, Xu Cindy, Avogadri Francesca, Wei Ge, Moran Susan, Roth Patrick 28 Mar 2022, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28 , p. 2270-2277 8 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet